molecular characteristics associated with increased risk of disease progression in smm
Published 6 months ago • 182 plays • Length 3:23Download video MP4
Download video MP3
Similar videos
-
3:28
molecular prognostication in smm
-
1:57
using molecular abnormalities for risk stratification in multiple myeloma at the time of diagnosis
-
1:50
molecular characteristics of extramedullary myeloma
-
2:26
serum biomarkers as predictors of disease progression in smoldering myeloma
-
1:11
advances that have been made in the molecular characterization of multiple myeloma
-
3:41
can novel immunotherapies cure multiple myeloma?
-
5:19
a 17-year fight against multiple myeloma
-
4:20
leukemia made easy || (usmle/comlex/nclex/imgs)
-
1:32
epigenetic drivers of disease progression in multiple myeloma
-
1:13
using integrative multiomics to explain myeloma progression and evolution of refractory disease
-
1:53
improving the risk stratification of patients with smoldering myeloma
-
1:13
molecular mrd as a prognostic marker for aml patients with mutated cebpa
-
1:08
the impact of extramedullary multiple myeloma on outcomes with ide-cel
-
2:16
analyzing genetic and epigenetic markers of high-risk multiple myeloma
-
1:38
the genomic definition of high-risk myeloma
-
4:10
genomic profiling smm
-
1:23
investigating bispecific antibodies in high-risk smoldering myeloma: the immunoprism platform study
-
2:20
ultra high-risk myeloma
-
1:45
how should we utilizing molecular data to improve all treatment?
-
3:00
processes leading to the development of hyperdiploidy in multiple myeloma
-
2:02
rwd from insight-mm: duration of therapy and treatment sequencing